![]() The Ordinary’s extended portfolio of retinoids includes the following formulations: If you have interest in a retinol product, please refer to our Retinol portfolio above which products contain pure retinol and cost less since many retinol technologies cost less than their next-generation counterparts like Granactive Retinoid™. These technologies cannot be compared directly with retinol itself in terms of concentration because they include a different retinoid molecule, in a similar way that Retinol cannot be compared with Retinoic Acid in terms of concentration. This product uses next-generation retinoid active technologies which have been shown to achieve better reduction in signs of aging than retinol without irritation. HPR is a highly-advanced form of retinoid which is, in fact, a non-prescription ester of all-trans direct retinoic acid that offers a multi-fold better effect against signs of aging than retinol, retinyl palmitate and nearly all other forms of non-prescription retinoid ī) A sustained-delivery form of pure retinol in a protective capsule system which supports both the delivery and the effect of Granactive Retinoid™.īoth forms of retinoid used avoid the irritation associated with retinoids (including retinol) use while delivering better visible results against signs of aging. This formulation combines two forms of next-generation retinoid actives:Ī) A 2% concentration of Granactive Retinoid™ which is a complex of solubilized Hydroxypinacolone Retinoate (HPR). The formula continues to offer an emulsion of 2% of the same advanced retinoid complex. S of late August 2017, The Ordinary’s portfolio of retinoids has been extended based on valuable consumer feedback and, as part of these introductions, Advanced Retinoid 2% has been renamed to Granactive Retinoid 2% Emulsion to align with the new naming direction of the extended range.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |